Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

12 March 2002

Evaluation of oxidative stress indices during treatment in pregnant women with intrauterine growth retardation.

Jacek Suzin, Agata Karowicz-Bilińska, Piotr Sieroszewski

Med Sci Monit 2002; 8(3): CR211-216 :: ID: 420889

Abstract

BACKGROUND: We investigated treatment-related changes in oxidative stressindices in intrauterine growth retardation (IUGR) during pregnancy. Four parameters of cell membranedestruction were measured: malondialdehyde, Schiff bases, lipid peroxides, and conjugated dienes. MATERIAL/METHODS:The study population included pregnant women under treatment in the Department of Obstetrics and Gynecologyat the Medical University of Łódź in 1997-1999, divided into two groups: (I) - 30 healthy pregnantwomen, (II) - 31 pregnant women with a clinical and ultrasound diagnosis of IUGR. The course of treatmentconsisted of ten days of intravenous injections of cocarboxylase, Vitamin C, and solcoseryl as antioxidantfactors. The parameters of oxidative stress were measured on the first day of hospitalization, afterfive days of treatment, and on the 10th day of treatment. RESULTS: The mean value of MDA concentrationin Group I was 2.03, vs. 2.39 in Group II. The mean value of conjugated dienes was 2.40 in Group I and2.41 in Group II. The Schiff bases concentration in Group I was 8.03, as opposed to 8.83 in Group II.The concentration of lipid peroxides was 0.113 in Group I and 0.134 in Group II. We found that all theparameters of oxidative stress were higher in IUGR than in normal pregnancy. At the end of treatmenta decrease was observed in all oxidative stress parameters. CONCLUSIONS: IUGR is correlated with an increasein membrane damage parameters. Therapy for IUGR decreased the values of all indices of oxidative stress.

Keywords: Actihaemyl, Ascorbic Acid, Fetal Growth Retardation, Lipid Peroxidation, Pregnancy, Research Support, Non-U.S. Gov, Thiamine Pyrophosphate

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750